Press Releases
Feb. 10, 2026
Revealed: The Stories of Fallen Athletes Depicted on Vladyslav Heraskevych’s Banned Olympic Helmet
Neutral
EIN Presswire
Feb. 11, 2026
NYC eye surgeon performs Eye Jewelry implant + Eye Tattoo
Neutral
EIN Presswire
Feb. 13, 2026
Star Equity Holdings, Inc. Declares Cash Dividend of $0.25 Per Share of 10% Series A Cumulative Perpetual Preferred Stock
Indeterminate
GlobeNewswire, Inc.
Feb. 13, 2026
Astrotech Reports Second Quarter of Fiscal Year 2026 Financial Results
Indeterminate
GlobeNewswire, Inc.
Feb. 9, 2026
Humacyte Announces New U.S. Department of Defense Funding for Procurement of Bioengineered Blood Vessels
Indeterminate
GlobeNewswire, Inc.
Feb. 12, 2026
Philip R. Lane: Bulgaria and the euro
Gov't Institution
ECB - European Central Bank
Owner: European Union
Feb. 12, 2026
Air Canada Reports Fourth Quarter and Full Year 2025 Financial Results
Indeterminate
GlobeNewswire, Inc.
Feb. 13, 2026
Radware Announces New $80 Million Share Repurchase Plan
Indeterminate
GlobeNewswire, Inc.
Feb. 9, 2026
BIO-Europe® Innovation Statement
Neutral
EIN Presswire
Feb. 12, 2026
Euronet Reports Fourth Quarter and Full Year 2025 Financial Results
Indeterminate
GlobeNewswire, Inc.
Jan. 30, 2026
Immunocore announces R&D leadership evolution
Indeterminate
GlobeNewswire, Inc.
Feb. 12, 2026
Conduent Reports Fourth Quarter and Full Year 2025 Financial Results
Indeterminate
GlobeNewswire, Inc.
Feb. 11, 2026
A New Era in Long-Haul: Air Canada to Acquire Airbus A350-1000 Widebody Aircraft to Support International Network Growth
Indeterminate
GlobeNewswire, Inc.
Feb. 11, 2026
Pilgrim’s Pride Reports Fourth Quarter and Year-End 2025 Results
Indeterminate
GlobeNewswire, Inc.
Jan. 22, 2026
EMUNO Therapeutics Achieves Research Milestone with Enamine's IDD Platform
Neutral
EIN Presswire
Feb. 2, 2026
Aquestive Therapeutics Announces FDA Issuance of Complete Response Letter for Anaphylm™
Indeterminate
GlobeNewswire, Inc.